Literature DB >> 33232724

Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.

Iman Akbarzadeh1, Maliheh Keramati2, Amir Azadi3, Elham Afzali4, Rasoul Shahbazi4, Mohsen Chiani2, Dariush Norouzian2, Haleh Bakhshandeh5.   

Abstract

Niosomes, as a kind of drug delivery system, is widely used for the topical delivery of lipophilic drugs. Optimization of niosomes plays an essential role in enhancing their therapeutic efficiencies. This study aims to prepare an optimized niosomal formulation of simvastatin (nSIM), a lipophilic member of statins, through the experiment (Response Surface methodology). Optimized niosomes were characterized in size, polydispersity index (PDI), entrapment efficiency (EE), stability, releasing pattern, and antimicrobial activity. The different molar ratio of surfactant and cholesterol were applied to prepare various formulation of simvastatin loaded niosome. Mean particle size and size distribution were analyzed by dynamic light scattering. Antibacterial activity was determined by MIC and MBC tests against Staphylococcus aureus and Escherichia coli. The release rate of simvastatin from noisome nanoparticles was studied by the Franz diffusion cell method. The release pattern was studied through zero order, first order, Higuchi, Korsmeyer-Peppas, and Hixson-Crowell kinetics models. Optimized niosomes were obtained by span 80, drug to cholesterol ratio of 0.4 with 7 min sonication time. Mean particle size, PDI, zeta potential, and entrapment efficiency (EE%) of optimized nSIM were obtained about 168 nm, 0.34, -32.40, and 96 %, respectively. The niosomes significantly decreased the drug's releasing rate and enhanced antibacterial activity against S. aureus and E. Coli. It was found that the release pattern of drug followed the Higuchi kinetic model which means drug release is by diffusion. Overall, our findings indicated that the prepared simvastatin loaded niosomes showed good stability and biological properties than free drug. Our study suggests that niosomal formulation could be considered as a promising strategy for the delivery of poor water-soluble drugs that enhance antibacterial activity.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; MTT assay; Niosome; Simvastatin

Year:  2020        PMID: 33232724     DOI: 10.1016/j.chemphyslip.2020.105019

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  7 in total

1.  Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum.

Authors:  Mana Najafzadeh; Haleh Bakhshandeh; Zahra Zamani; Monire Movahedi; Seyed Mohammad Atyabi
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

Review 2.  Niosomes: a novel targeted drug delivery system for cancer.

Authors:  Maryam Moghtaderi; Kamand Sedaghatnia; Mahsa Bourbour; Mahdi Fatemizadeh; Zahra Salehi Moghaddam; Faranak Hejabi; Fatemeh Heidari; Sameer Quazi; Bahareh Farasati Far
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

3.  Peri-implant marginal bone loss and systemic statin use: A retrospective cohort pilot study.

Authors:  Behzad Bahrami-Hessari; Leif Jansson
Journal:  Clin Exp Dent Res       Date:  2021-10-29

4.  Targeting therapy effects of composite hyaluronic acid/chitosan nanosystems containing inclusion complexes.

Authors:  Zhiwei Liang; Dongmei Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy.

Authors:  Farnaz Khodabakhsh; Mahsa Bourbour; Mohammad Tavakkoli Yaraki; Saina Bazzazan; Haleh Bakhshandeh; Reza Ahangari Cohan; Yen Nee Tan
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

Review 6.  Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach.

Authors:  Alexia Barbarossa; Antonio Rosato; Filomena Corbo; Maria Lisa Clodoveo; Giuseppe Fracchiolla; Antonio Carrieri; Alessia Carocci
Journal:  Antibiotics (Basel)       Date:  2022-06-17

7.  Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains.

Authors:  Mohamad Rahmati; Ebrahim Babapoor; Mehrouz Dezfulian
Journal:  World J Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 4.253

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.